| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.34 | 1e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.2 | 5e-05 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.12 | 9e-05 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.0001 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.22 | 0.0002 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |